ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study
NCT ID: NCT03646695
Last Updated: 2021-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-09-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition
NCT03465865
Foveal Sparing ILM Peeling With ILM Flap Transposition
NCT05897671
Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique
NCT04883697
ILM Peeling Versus Inverted Flap Technique for Treatment of Macular Hole: Near Visual Acuity Outcomes
NCT04698226
Inverted ILM Repositioning as Treatment for Full Thickness Macular Holes
NCT01228188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ILM flap
vitrectomy with ILM flap transposition and gas-tamponade will be performed
ILM flap transposition
during ILM flap Transposition, an ILM flap is placed on the macular hole
ILM peeling
vitrectomy with ILM peeling and gas-tamponade will be performed
ILM peeling
during ILM Peeling the ILM is removed around the macular hole
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ILM flap transposition
during ILM flap Transposition, an ILM flap is placed on the macular hole
ILM peeling
during ILM Peeling the ILM is removed around the macular hole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vienna Institute for Research in Ocular Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Prof. Dr. Oliver Findl, MBA
Head of Department of Ophthalmology, Professor, Principal Investigator, MBA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Findl, Professor
Role: PRINCIPAL_INVESTIGATOR
Head of Department of Ophthalmology, Professor, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILM flap
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.